Novozymes AS - Company Profile

Publication Date	February 2008
Publisher	RNCOS
Product Type	Report
Pages	30
ISBN Number	not applicable
Product Code	RCS00390

Price

£205.00
approximately: $400 | €259

PDF

PRINT £255 ($500 | €324)

CD-ROM £255 ($500 | €324)

Order above formats by FAX

Summary

Company Profile will assists individual investors, managers and companies in evaluating opportunities, trends, market innovations, and selecting appropriate information solutions in order to make effective decisions. The report has been made after extensive research using the data available from reliable publications, trade associations and the companies' sources.

The report elaborates on the company's business structure and operations, products and services. The report includes key financial information and strategic analysis that intends to aid investors to find better prospects with the company and gain an insight into the corporate policies.

Report Highlights

Provides a snapshot version of the company's performance, through its financials and charts to evaluate the company growth trends.
It offers key company data and analysis vis--vis to the major industry players. This information is vital from the point of estimating business strategies of the company and facilitate in decision-making process for the investors.
Provides key financial information of the company, sales and product ratio, revenue and income trend, stock performances for the most recently ended quarter, financial year across businesses, and product/service categories.
Tracks major M&A trends and developments undertaken in the current fiscal year to get a better understanding of company's growth strategies.
The report identifies and analyzes the company's strength and weaknesses to come up with the possible opportunities for the company.
The report comments on the company's outlook for the forthcoming periods both on strategic and financial point of views.
Supplemented with graphs and tabular information on the key industry players, overall financial and market performances, list of products and services, and company's share performances.

Content

1. Industry Snapshot
2. Company Overview
- 2.1 History
- 2.2 Business Overview
- 2.3 Organizational Structure
- 2.4 Major Mergers & Acquisitions
- 2.5 Ticker Codes at various Stock Exchange Listings
- 2.6 Management Profile
3. Product & Services
- 3.1 Product & Services - An Overview
- 3.2 Sales Summary by Geographical Distribution
- 3.3 Revenue Summary by Segment
4. Financial Information for Fiscal Year
- 4.1 Financial Summary
- 4.2 Breakup of Revenue & Sales Trends
- 4.3 Ratio & Market Indicators
- 4.4 Earning & Income Estimates
- 4.5 Stock Analysis (for the last three quarter)
5. Business Strategies
6. SWOT Analysis
- 6.1 Strength
- 6.2 Weaknesses
- 6.3 Opportunity
- 6.4 Threats
7. Top 5 Competitors (Sales, Profit, No. of Employees & Market Capitalization)
- 7.1 BioMarin Pharmaceutical Inc.
- 7.2 Danisco A/S
- 7.3 BASF
- 7.4 AB Enzymes
- 7.5 Theratase
8. Recent News
9. Analyst View
List of Figures:
- Figure 1-1: Global - Enzymes Market (in Billion US$), 2005-2007E & 2012F
- Figure 1-2: Global - Share of Enzymes Market by Application (%), 2007E
- Figure 3-1: Novozymes AS - Revenue by Geographical Distribution (in Billion DKK), 2006 & 2007
- Figure 3-2: Novozymes AS - Revenue by Product Segment (in Billion DKK), 2006 & 2007
- Figure 4-1: Novozymes AS - Stock Chart
List of Tables:
- Table 1-1: Global - Enzymes Market by Application (in Million US$), 2005-2007E & 2012F
- Table 2-1: Novozymes AS - Major Mergers & Acquisitions (2001 to 2006)
- Table 2-2: Novozymes AS - Ticker Codes at various Stock Exchanges
- Table 2-3: Novozymes AS - Management Profile
- Table 4-1: Novozymes AS - Financial Overview (in Million DKK), 2007
- Table 4-2: Novozymes AS - Breakup of Revenue & Sales (in Million DKK), 2005-2007
- Table 4-3: Novozymes AS - Profit Margins (2005-2007)
- Table 4-4: Novozymes AS - Key Financial Ratios (2004-2006)
- Table 4-5: Novozymes AS - Earning & Income Estimates (in Million DKK), 2005-2007
- Table 7-1: BioMarin Pharmaceutical Inc. - Key Financials (in Million US$), 2005, 2006 & Sep 2007
- Table 7-2: Danisco A/S - Key Financials (in Million DKK), 2004-05 to 2006-07
- Table 7-3: BASF - Key Financials (in Million Euro), 2005, 2006 & Sep 2007
- Table 7-4: Theratase - Key Financials* (in '000 GBP), 2005 & 2006